ASMB - Assembly Biosciences Inc logo

Assembly Biosciences Inc

ASMB

Assembly Biosciences develops antiviral therapeutics targeting viral diseases, focusing on chronic infections like hepatitis B and D, and herpesvirus. Its pipeline includes small-molecule candidates in clinical trials to improve patient outcomes globally.

โš•๏ธ Healthcare NASDAQ Listed 2010 $ USD
$1,000 invested 10 years ago โ†’$230today

Score Overview

1 Year
Scoreโ€”
Net Growthโ€”
Net Trendโ€”
Net Income Consistencyโ€”
Rev Growth3.52%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growthโ€”
Net TrendEvery year
Net Income Consistencyโ€”
Rev Growth11x
Rev Trend80%
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growthโ€”
Net Trend67%
Net Income Consistency
Rev Growthโ€”
Rev Trend80%
Revenue Consistency
All Time
Scoreโ€”
Net Growthโ€”
Net Trend53%
Net Income Consistency
Rev Growthโ€”
Rev Trend53%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Assembly Biosciences Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. ASMB does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-06
$ 22.18โ€”
1 Year2025-10-06
$ 24.48-9.40%
5 Years2021-10-06
$ 39.60-43.99%
10 Years2016-10-06
$ 96.36-76.98%
All Time2010-12-17
$ 378.00-94.13%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 74M$ 320M
2025$ 72M-$ 6M$ 248M
2024$ 28M-$ 40M$ 112M
2023$ 7M-$ 61M$ 130M
2022$ 0.00-$ 92M$ 91M
2021$ 6M-$ 129M$ 146M
2020$ 79M-$ 62M$ 216M
2019$ 15M-$ 97M$ 274M
2018$ 14M-$ 90M$ 218M
2017$ 9M-$ 42M$ 119M
2016$ 0.00-$ 44M$ 52M
2015$ 0.00-$ 28M$ 67M
2014$ 0.00-$ 23M$ 29M
2013$ 0.00-$ 19M$ 27M
2012$ 0.00-$ 24M$ 20M
2011$ 0.00-$ 34M$ 36M
IPO2010-$ 15M$ 14M
ASMB - Assembly Biosciences Inc logo

Assembly Biosciences Inc fundamental performance

Across Assembly Biosciences Inc's full reported history, from 2010 to 2025, net income went from -$ 15M to -$ 6M. Revenue increased in 53% of the years measured; net income in 53%.

Membership

Explore ASMB with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,122 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies